Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
8,564,394
-
Total 13F shares
-
2,876,709
-
Share change
-
+768,591
-
Total reported value
-
$7,101,619
-
Price per share
-
$2.47
-
Number of holders
-
23
-
Value change
-
+$1,897,087
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) as of Q3 2025
As of 30 Sep 2025,
Edesa Biotech, Inc. - Common Shares, without par value (EDSA) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,876,709 shares.
The largest 10 holders included
Velan Capital Investment Management LP, Stonepine Capital Management, LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and CITADEL ADVISORS LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.